← Research library

Dalargin and liver function during acute hypoxia

Animal research · 2000

What was studied
Rats; pressure-chamber model reported as approximately 12,200 m
Main finding
The dissertation transcription reports longer survival in severe hypobaric hypoxia at testing times through 168 hours after ordinary intravenous administration and through 336 hours with erythrocyte-carrier delivery. Liver and oxidative-stress markers varied by delivery method and time.

Study data at a glance

Participants or experimental model
Rats; pressure-chamber model reported as approximately 12,200 m
Reported results
The dissertation transcription reports longer survival in severe hypobaric hypoxia at testing times through 168 hours after ordinary intravenous administration and through 336 hours with erythrocyte-carrier delivery. Liver and oxidative-stress markers varied by delivery method and time.
Study limitations and source details

Study limitations

  • Rat experiments do not establish human altitude protection or a seven-day clinical effect.
  • Original scan and survival tables remain to be reconciled; numerical survival values are withheld.
  • The early time point appears as 0.15 hours in the transcription; it is not safely interpretable as 15 minutes.

Source details

Selected source text and metadata checked; full risk-of-bias review pending.

Selected text reviewed

Sources checked

Citation

Animal / experimentalRussian-language source

V. Yu. Kalinin. Dalargin and liver function during acute hypoxia Candidate dissertation, 2000; web transcription

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards